Deal Announcements

Quinnova Pharma Raises Series B Venture Capital

Friday, October 30, 2009 5:54:00 AM PDT | VentureDeal Staff

Newtown, Pennsylvania  --  Specialty pharmaceutical company Quinnova Pharmaceuticals has garnered $17.4 million in its second round of venture capital investment.

Quinnova says that it utilizes a reformulation strategy that uses already proven pharmaceutical ingredients delivered in unique and patent protected delivery system.

Safeguard Scientifics was the lead investor in the round, which also included Thomas, McNerny & Partners, HIG Ventures and Omnivest.  The company said it would use the funding proceeds to fund a Phase III clinical trial for an unnamed product.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1